Health
AstraZeneca effective against Brazil variant – source – Chronicle
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian…
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian variant of the disease. Colette Luke has more.
Continue Reading
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News21 hours agoMeasles alert issued across popular south-east attractions
-
General15 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts